Key Insights

Highlights

Treatment Research

2 treatments under study, led by Hypothetical Genomic Scenarios At Followup

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1
Withdrawn1

Clinical Trials (2)

Research Network

Common Treatments

  • Hypothetical Genomic Scenarios At Followup1
  • Genetics Education At Baseline1

Active Sponsors

  • Brigham and Women's Hospital1
  • University Hospital, Clermont-Ferrand1
  • Clermont Auvergne Métropole1
  • Auvergne perinatal network1

Top Investigators

Related Conditions

  • Pregnant Women And Partners1

Activity Timeline